Cure8 research brief
Children with Crohn's and their clinicians often need noninvasive, accessible ways to monitor small-bowel disease. If validated elsewhere, IUS with the reported BWT thresholds could reduce reliance on MRE, which is costlier and less available.
Pediatric gastroenterologists, radiologists and sonographers who manage children with Crohn's disease; parents and caregivers of pediatric IBD patients interested in imaging options; researchers studying noninvasive disease monitoring.
This is a prospective diagnostic study of 78 children with Crohn's disease who had IUS within 7 days of routine MRE. The authors compared IUS-measured bowel wall thickness and existing IUS scores against MRE segmental disease grading for the terminal ileum (TI), ileum, and jejunum.
The study found high accuracy for IUS BWT to detect disease in the TI (AUC 0.91) with an optimal cut-off of 2.4 mm, and good accuracy in the ileum (AUC 0.80) with an optimal cut-off of 2.0 mm (reported sensitivity 76% and specificity 93%). The jejunum had fewer affected segments, limiting reliable cut-off determination.
Previously published IUS scoring systems did not outperform simple BWT measurement in this cohort. Practical takeaways: The authors conclude IUS is a reliable, noninvasive tool to assess small-bowel Crohn's activity in children, and provide candidate BWT thresholds for the TI and ileum that could help standardize interpretation.
This entry is based on the journal abstract (Journal of Pediatric Gastroenterology and Nutrition). The study population was 78 pediatric patients and comparisons were made against MRE as the reference standard. The jejunal findings were limited by low numbers, and the results should be validated in larger, independent pediatric cohorts before changing clinical protocols.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
This study could clarify which imaging test—MRE or IUS—is more accurate or appropriate for monitoring treatment response in Crohn's disease, potentially standardising follow-up and informing patient and clinician...
Imaging and endoscopy can give different pictures of disease activity in newly diagnosed pediatric Crohn’s disease. That matters because treatment decisions often rely on how active disease appears and where it’s...
IBD patients can have lung involvement without symptoms. Simple spirometry focused on small-airway measures might help detect early pulmonary changes and prompt further evaluation or monitoring.
